sr 31 peptide mitochondrial targeted peptide SS-31 - SS-31peptidedosage Invitrogen Human SR-BI Peptide Unveiling the Potential of SS-31 Peptide: A Mitochondrial-Targeting Therapeutic

SS-31peptidedosage The sr 31 peptide, also known by its scientific designation SS-31, has emerged as a significant area of research within the biomedical community. This mitochondria-targeting peptide exhibits a remarkable ability to protect and repair cellular mitochondria, the powerhouses of our cellsSS-31 is a mitochondria-targeted peptide, which has been shown to be highly effective in protecting and healing mitochondria damage.. With a growing body of scientific literature, SS-31 is demonstrating considerable promise in addressing a range of age-related conditions and diseases by improving mitochondrial function.

At its core, SS-31 is a synthetic peptide with a unique structureHuman SR-BI Synthetic Peptide (PEP-0870). It is often described as a unique tetrapeptide composed of alternating cationic and aromatic residues.2025年8月9日—These abnormalities were reversed by treating DCMA fibroblasts withSS-31, a synthetic peptidethat localizes to the inner mitochondrial ... This specific design allows SS-31 to efficiently accumulate within the inner mitochondrial membrane, a crucial location for its therapeutic effects. The primary mechanism by which SS-31 operates is through its potent antioxidant properties.SS-31, also known as also known as MTP-131, elamipretide and Bendavia,is a unique tetrapeptide that specifically targets the mitochondria within cells. It acts as a scavenger of mitochondrial reactive oxygen species (ROS), thereby reducing oxidative stress, a major contributor to cellular damage and aging.IL-31 Peptide(Cat. No. 3747P) is used for blocking the activity of IL-31Antibody.

Research has extensively documented the beneficial effects of SS-31 peptide across various biological systems.作者：JD Chavez·2020·被引用次数：176—SS-31 is a synthetic peptide that improves mitochondrial functionand is currently undergoing clinical trials for treatments of heart failure, ... Studies indicate that this mitochondrial targeted peptide SS-31 can rapidly reverse in vivo deficits in mitochondrial energetics, particularly in aged tissuesSS-31(also known as Bendavia, Elamipretide, and MTP-131) is a smallpeptidethat accumulates in mitochondria and scavenges reactive oxygen species.. This suggests a significant role for SS-31 in combating age-related decline in cellular energy production. For instance, treatment with SS-31 rapidly reverses in vivo deficits in mitochondrial energetics in skeletal muscle, leading to improved muscle function. Furthermore, SS-31 exerts beneficial effects on the leukocytes of T2D patients by reducing oxidative stress, inflammation, and other detrimental processes.SS-31 is a mitochondria-targeted peptide, which has been shown to be highly effective in protecting and healing mitochondria damage.

The therapeutic applications of SS-31 are broad and continue to expand.SS-31 Peptide: Research in Mitochondrial Functionality Its ability to protect mitochondria makes it a compelling candidate for addressing conditions characterized by mitochondrial dysfunction.Human SR-BI Synthetic Peptide (PEP-0870) This includes a spectrum of diseases such as heart failure, kidney disease, and neurodegenerative disorders. For example, SS-31 is a peptide used to target mitochondria and has been found to protect the kidneys from oxidative stress, inflammation, and apoptosis, offering a new avenue for the treatment of kidney diseaseCathelicidin antimicrobial peptide. In the realm of cardiovascular health, beneficial effects of SS-31 peptide on cardiac function have been observed, showing its potential in improving cardiac mitochondrial dysfunction.

Beyond its direct impact on organ systems, SS-31 has shown a compelling amount of promise in slowing or mitigating aging-related changes2026年1月2日—Pharmaceutical-grade mitochondria-targeting peptidedesigned to protect against oxidative stress, restore cellular energy production, and .... This includes its potential to slow or reverse age-related visual decline, suggesting a role in preserving visual acuity as individuals age.2026年1月2日—Pharmaceutical-grade mitochondria-targeting peptidedesigned to protect against oxidative stress, restore cellular energy production, and ... The broad-spectrum restorative capabilities of SS-31 are also being explored in other contexts, such as its capacity to reverse burn-induced insulin resistance, providing a solid preclinical basis for its application in metabolic disorders.

While SS-31 is gaining attention, it's important to note that it is a subject of ongoing clinical trials. It is also known by other names, including Elamipretide, Bendavia, and MTP-131.作者：C Wang·2025·被引用次数：3—Research indicates that SS31, a mitochondria-targeted peptide,can reverse mitochondrial dysfunctionand ameliorate conditions in musculoskeletal disease models ... The SS-31 peptide is a pharmaceutical-grade mitochondria-targeting peptide designed to protect against oxidative stress, restore cellular energy production, and address various cellular dysfunctionsIL-31 Peptide - Cat. No. 3747P.

In summary, the sr 31 peptide represents a groundbreaking advancement in the development of mitochondria-focused therapeutics.SS-31 is a mitochondria-targeted peptide, which has been shown to be highly effective in protecting and healing mitochondria damage. Its well-established ability to target and protect mitochondria, coupled with its demonstrated efficacy in preclinical studies across a range of conditions, positions it as a peptide with significant potential for addressing age-related diseases and improving overall cellular health. Further research and clinical trials are expected to solidify its role as a valuable therapeutic agent.